123 related articles for article (PubMed ID: 10679740)
1. Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients.
Danesi DT; Spanò M; Fabiano A; Altavista P; Pasqualetti P; Toscano MG; Antonini F; Catalano P; Mecozzi A; Picconi A; Daffinà A; Cucchiara G
Cytometry; 2000 Feb; 42(1):27-34. PubMed ID: 10679740
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
5. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
7. Adenoid cystic carcinoma of the trachea and bronchus--a clinicopathologic study with DNA flow cytometric analysis and oncogene expression.
Lin CM; Li AF; Wu LH; Wu YC; Lin FC; Wang LS
Eur J Cardiothorac Surg; 2002 Oct; 22(4):621-5. PubMed ID: 12297183
[TBL] [Abstract][Full Text] [Related]
8. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric and immunohistochemical correlations in high incidence human solid tumors.
Danesi DT; Spanò M; Antonini F; Altavista P; Catalano P; Cordelli E; Pasqualetti P; Santacroce C; Toscano MG; Mecozzi A; Fabiano A
Tumori; 1997; 83(3):689-97. PubMed ID: 9267490
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the prognostic significance of DNA ploidy patterns in gastric cancer.
Tirindelli Danesi D; Cucchiara G; Picconi A; Daffinà M; Fabiano A; Antonini F; Toscano MG; Pasqualetti P; Altavista P; Cordelli E; Spanò M
Eur J Histochem; 1997; 41 Suppl 2():147-8. PubMed ID: 9859824
[No Abstract] [Full Text] [Related]
11. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
13. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N
Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.
Victorzon M; Roberts PJ; Haglund C; von Boguslawsky K; Nordling S
Oncology; 1996; 53(3):182-91. PubMed ID: 8643219
[TBL] [Abstract][Full Text] [Related]
16. Highly aggressive behavior and poor prognosis of small-cell carcinoma in the alimentary tract: flow-cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen.
Kimura H; Konishi K; Maeda K; Yabushita K; Tsuji M; Miwa A
Dig Surg; 1999; 16(2):152-7. PubMed ID: 10207243
[TBL] [Abstract][Full Text] [Related]
17. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer.
Setälä L; Kosma VM; Lipponen P; Naukkarinen A; Nordling S; Hollmén S; Eskelinen M; Syrjänen K; Alhava E
J Cancer Res Clin Oncol; 1998; 124(9):497-502. PubMed ID: 9808424
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
20. Proliferation kinetics and prognosis in gastric cancer after resection.
Sendler A; Gilbertz KP; Becker I; Mueller J; Berger U; Fink U; van Beuningen D; Siewert JR
Eur J Cancer; 2001 Sep; 37(13):1635-41. PubMed ID: 11527689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
